JPMorgan Chase Bank, N.A. ("JPMorgan") provides sub-administration and sub-accounting services to the Fund pursuant to an agreement with New York Life Investments. These services include calculating the daily NAVs of the Fund, maintaining the general ledger and sub-ledger accounts for the calculation of the Fund's NAVs, and assisting New York Life Investments in conducting various aspects of the Fund's administrative operations. For providing these services to the Fund, JPMorgan is compensated by New York Life Investments.
Pursuant to an agreement between the Fund and New York Life Investments, New York Life Investments is responsible for providing or procuring certain regulatory reporting services for the Fund. The Fund will reimburse New York Life Investments for the actual costs incurred by New York Life Investments in connection with providing or procuring these services for the Fund.
(B) Transfer, Dividend Disbursing and Shareholder Servicing Agent. Computershare Trust Company, N.A. (“Computershare”), 150 Royall Street, Canton, Massachusetts, 02021, is the Fund’s transfer, dividend disbursing and shareholder servicing agent pursuant to an agreement between the Fund and Computershare.
Note 4-Federal Income Tax
As of November 30, 2021, the cost and unrealized appreciation (depreciation) of the Fund’s investment portfolio, including applicable derivative contracts and other financial instruments, as determined on a federal income tax basis, were as follows:
| Federal Tax Cost | Gross Unrealized Appreciation | Gross Unrealized (Depreciation) | Net Unrealized Appreciation/ (Depreciation) |
Investments in Securities | $1,339,437,889 | $9,113,173 | $(46,455,409) | $(37,342,236) |
Note 5–Custodian
JPMorgan is the custodian of cash and securities held by the Fund. Custodial fees are charged to the Fund based on the Fund's net assets and/or the market value of securities held by the Fund and the number of certain transactions incurred by the Fund.
Note 6–Line of Credit
The Fund maintains a line of credit under a credit agreement with The Bank of New York Mellon ("BNY Mellon") dated November 4, 2021 (the "Credit Agreement") in order to achieve its investment objective. The aggregate commitment amount is $350,000,000. Under the Credit Agreement, the Fund is subject to (i) a financing charge of the Overnight Bank Funding Rate plus 0.75% on drawn assets and (ii) a commitment fee at an annual rate of 0.25% of undrawn portions of the credit facility to the extent the credit facility utilization rate is less than 80%. The Credit Agreement expires on May 3, 2022. During the period October 27, 2021 (inception date) through November 30, 2021, the Fund utilized the line of
credit for 15 days, maintained an average daily balance of $234,000,000 at a weighted average interest rate of 0.82% and incurred interest expense in the amount of $85,679. As of November 30, 2021, borrowings outstanding with respect to the Fund under the Credit Agreement were $311,500,000. Effective November 30, 2021, the Fund's aggregate commitment amount was increased to a total of $500,000,000.
Note 7–Purchases and Sales of Securities (in 000’s)
During the period October 27, 2021 (inception date) through November 30, 2021, purchases of securities, other than short-term securities, were $1,339,446. The Fund was launched during the period and began to invest its capital. Hence, all securities were purchased during the reporting period and no securities were sold.
Note 8–Capital Share Transactions
Transactions in capital shares for the period October 27, 2021 (inception date) through November 30, 2021, were as follows:
Common Shares | Shares | Amount |
Period October 27, 2021 (inception date) through November 30, 2021: | | |
Shares sold | 50,005,000 | $1,000,100,000 |
Note 9–Other Matters
An outbreak of COVID-19, first detected in December 2019, has developed into a global pandemic and has resulted in travel restrictions, closure of international borders, certain businesses and securities markets, restrictions on securities trading activities, prolonged quarantines, supply chain disruptions, and lower consumer demand, as well as general concern and uncertainty. The continued impact of COVID-19 and related new variants is uncertain and could further adversely affect the global economy, national economies, individual issuers and capital markets in unforeseeable ways and result in a substantial and extended economic downturn. Developments that disrupt global economies and financial markets, such as COVID-19, may magnify factors that affect the Fund's performance.
Note 10–Subsequent Events
In connection with the preparation of the financial statements of the Fund as of and for the period October 27, 2021 (inception date) through November 30, 2021, events and transactions subsequent to November 30, 2021, through the date the financial statements were issued have been evaluated by the Manager for possible adjustment and/or